Oxidative stress in diabetic macrovascular disease: Does homocysteine play a role?

被引:20
作者
Fonseca, VA
Stone, A
Munshi, M
Baliga, BS
Aljada, A
Thusu, K
Fink, L
Dandona, P
机构
[1] JOHN L MCCLELLAN MEM VET ADM MED CTR,DEPT PATHOL,LITTLE ROCK,AR
[2] JOHN L MCCLELLAN MEM VET ADM MED CTR,DIV ENDOCRINOL & METAB,LITTLE ROCK,AR
[3] UNIV ARKANSAS MED SCI,LITTLE ROCK,AR 72205
[4] MILLARD FILLMORE HOSP,DIV ENDOCRINOL,BUFFALO,NY
关键词
D O I
10.1097/00007611-199709000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Non-insulin-dependent diabetes mellitus (NIDDM) and hyperhomocysteinemia are both associated with increased lipid peroxidation (oxidative stress). This may contribute to the accelerated Vascular disease associated with these conditions. It is not known whether the coexistence of elevated homocysteine levels will stimulate oxidative stress further than that caused by diabetes alone. Methods. Plasma concentrations of thiobarbituric acid reactive substances (TBARS), an index of lipid peroxidation, were measured in patients with NIDDM who had previously had a methionine load test; some of the patients had hyperhomocysteinemia. Results. Plasma TBARS concentrations were elevated in diabetics with vascular disease. The additional presence of hyperhomocysteinemia was not associated with a further increase in plasma TBARS concentrations. Conclusions. Lipid peroxidation is increased in patients with diabetes mellitus and macrovascular disease and is not further elevated by the coexistence of elevated homocysteine levels. It is possible that diabetes maximally stimulates oxidative stress and any further acceleration of vascular disease in patients who have coexistent hyperhomocysteinemia is mediated through mechanisms other than lipid peroxidation.
引用
收藏
页码:903 / 906
页数:4
相关论文
共 21 条
[1]  
ALJADA A, 1995, DIABETES, V44, pA113
[2]   LIPID-PEROXIDATION AND RETINOPATHY IN STREPTOZOTOCIN-INDUCED DIABETES [J].
ARMSTRONG, D ;
ALAWADI, F .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (04) :433-436
[3]   LIPID-PEROXIDATION AND SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO IN-VITRO OXIDATION IN HYPERHOMOCYSTEINAEMIA [J].
BLOM, HJ ;
KLEINVELD, HA ;
BOERS, GHJ ;
DEMACKER, PNM ;
HAKLEMMERS, HLM ;
POELEPOTHOFF, MTWBT ;
TRIJBELS, JMF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (03) :149-154
[4]   INHIBITION OF LOW-DENSITY OXIDATION IN-VITRO BY THE 6-HYDROXY-METABOLITES AND 7-HYDROXY-METABOLITES OF DOXAZOSIN, AN ALPHA(1)-ADRENERGIC ANTIHYPERTENSIVE AGENT [J].
CHAIT, A ;
GILMORE, M ;
KAWAMURA, A .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (02) :159-167
[5]   Oxidative damage to DNA in diabetes mellitus [J].
Dandona, P ;
Thusu, K ;
Cook, S ;
Snyder, B ;
Makowski, J ;
Armstrong, D ;
Nicotera, T .
LANCET, 1996, 347 (8999) :444-445
[6]   CIRCULATING LIPID HYDROPEROXIDE LEVELS IN HUMAN HYPERHOMOCYSTEINEMIA - RELEVANCE TO DEVELOPMENT OF ARTERIOSCLEROSIS [J].
DUDMAN, NPB ;
WILCKEN, DEL ;
STOCKER, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (04) :512-516
[7]   Oxidative stress and diabetic vascular complications [J].
Giugliano, D ;
Ceriello, A ;
Paolisso, G .
DIABETES CARE, 1996, 19 (03) :257-267
[8]   ENHANCED SERUM LEVELS OF THIOBARBITURIC ACID-REACTIVE SUBSTANCES IN DIABETES-MELLITUS [J].
GRIESMACHER, A ;
KINDHAUSER, M ;
ANDERT, SE ;
SCHREINER, W ;
TOMA, C ;
KNOEBL, P ;
PIETSCHMANN, P ;
PRAGER, R ;
SCHNACK, C ;
SCHERNTHANER, G ;
MUELLER, MM .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05) :469-475
[9]  
GUGLIANO D, 1996, DIABETES CARE, V19, P257
[10]   HOMOCYSTEINE AND OTHER SULFHYDRYL COMPOUNDS ENHANCE THE BINDING OF LIPOPROTEIN(A) TO FIBRIN - A POTENTIAL BIOCHEMICAL LINK BETWEEN THROMBOSIS, ATHEROGENESIS, AND SULFHYDRYL COMPOUND METABOLISM [J].
HARPEL, PC ;
CHANG, VT ;
BORTH, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10193-10197